Phocas Financial’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
Other funds holding ZVRA
Phocas Financial's ZVRA Position: Q3 2026 in Review
Phocas Financial sold out of Zevra Therapeutics (ZVRA) in Q3 2026, closing a stake of 295,907 shares — an estimated $4.24M sold.
Phocas Financial first reported a position in ZVRA in Q1 2026 and held it in 2 quarters. The position peaked at $4.24M in Q2 2026. 129 funds tracked by Wall St. Rank hold ZVRA as of Q3 2026.
- Phocas Financial reported no remaining Zevra Therapeutics position as of Q3 2026 after selling out during the quarter.
- Phocas Financial sold 295,907 Zevra Therapeutics shares in Q3 2026, an estimated $4.24M.
- Phocas Financial first reported a position in Zevra Therapeutics in Q1 2026 and held it in 2 quarters.
- Phocas Financial's Zevra Therapeutics position peaked at $4.24M in Q2 2026.
- 129 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2026.
Based on Phocas Financial's 13F filing for Q3 2026.